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Introduction
 Cervical cancer accounts for 15% of all female cancers 
in developing countries (Ferlay et al., 2000). According 
to Globocan (2008) data, it is the third most common 
gynecologic cancer (except breast cancer) in Turkey; its 
incidence is 4.2/100000, 1443 new cases and 556 deaths 
per year is reported (Globocan, 2008).
 Due to the long preinvasive state, invasive cervical 
cancer has been considered a preventable disease. For this 
reason screening programmes are widely used in many 
developed and developing countries. Pap smear is the 
principal method for cervical cancer screening. Improper 
management of preinvasive lesions can increase the risk 
of cervical cancer, on the other hand overtreatment can 
cause some complications such as preterm delivery.
 Generally accepted procedure for the management 
of cytologic abnormalities is colposcopy (Kyrgiou et al., 
2007). The see and treat strategy is an alternative procedure 
for women with abnormal cytology, which provides 
immediate and concomitant diagnosis and treatment 
without previous biopsy. The most common treatment 
method used in this approach is loop electrosurgical 
excision procedure (LEEP). Another management strategy 
is colposcopy directed biopsy, and if hystology is found 
to be cervical intraepithelial neoplasia (CIN) 2/3, LEEP 
is performed, this is called “three step strategy”.
 For cytologic high grade squamous intraepithelial 
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Abstract
 Background: To investigate the indications of loop electrosurgical excision procedure (LEEP) and its 
overtreatment rates for the see and treat and three step strategies in cases of atypical squamous cells of 
undetermined cytology (ASC-US) and low grade intraepithelial neoplasia (LGSIL) cytology. Materials and 
Methods: We retrospectively analyzed colposcopy directed biopsy (CDB) and LEEP results of 176 paients with 
ASC-US or LGSIL cytologies who underwent colposcopic examination. Results: Initial cytologies were ASCUS 
in 120 women and LGSIL in 56. According to the see and treat approach immediate LEEP was performed for38 
women. Among the remaining 138 women, LEEP was performed for 32 whose CDB results revealed CIN2/3 
lesions. In the see and treat group the recognition of CIN2/3 was found to be 39.4%. The overtreatment rate was 
60% as compared to 25% in the three step group. In CDB group detection of CIN 2 or greater lesions increased 
with 3 or more biopsies. Conclusions: In patients with ASC-US/LGSIL cytologies CDB should be performed 
before LEEP to prevent overtreatment, with attention to all suspected areas and more than 2 biopsies taken. 
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and treat’’ by LEEP outweight the risk of overtreatment 
(Cho and Kim, 2009; Zhi Gang Li et al., 2009; Paula et 
al., 2012). On the other hand the role of LEEP in minor 
cytologic abnormalities as atypical squamous cells 
of undetermined cytology (ASC-US) and low grade 
intraepithelial neoplasia (LGSIL ) remains unclear. There 
are few reports in this issue (Cho and Kim, 2009). In this 
study we searched indications, overtreatment rates and 
necessity of LEEP in ASCUS and LGSIL cytology.
Materials and Methods
 We reviewed the medical reports of women who 
underwent colposcopic examination for minor cytological 
abnormalities (ASCUS and LGSIL) at the Baskent 
University Istanbul Hospital between January 2008 
and January 2013. Colposcopies for HGSIL, Atypical 
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Atypical Squamous Cells can not exclude HSIL (ASC-H) 
cytologies; normal pap smear results and pregnant women 
were all excluded. Some patients with ASCUS results were 
followed up with repeat cytology. If the repeat cytologies 
were normal, colposcopic examination and biopsy were 
not performed. These patients were not included. 
 Pap smear before colposcopy, patient’s age, gravidy 
and parity were documented. Pap smear results were 
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(Solomon et al., 2005). All cervical smears were 
conventional Pap smears.
 Colposcopic examination was carried out after 
application of 4% acetic acid solution to cervix. After 
the examination with acetic acid, lugols iodine solution 
was performed. Visualization of the entire transformation 
zone was essential for adequate colposcopic examination. 
Patients’ management were planned according to 
satisfactory colposcopy, visulalization of transformation 
zone and squmaocolumnar junction, asetowhite lesions, 
enlargement and margins of the lesions and pattern of the 
vessels. Patients with normal and satisfactory colposcopic 
examinations ; no biopsy performed and they were 
not included in this study. Patients with unsatisfactory 
colposcopy, suspection of HGSIL, multiple and large 
lesions were treated with see and treat strategy. In some 
patients without HGSIL suspection LEEP was performed 
for patients’ wish for maximum safety. All of these patients 
had completed their families. Colposcopy-directed biopsy 
was performed for other patients. Endocervical curettage 
was also performed in all LGSIL patients. Biopsies were 
performed from all suspected areas and multiple biopsies 
were taken. If the biopsy results were CIN 2/3; LEEP was 
carried out as three step strategy.
 LEEP was performed under general or local anesthesia 
at an outpatient department. The procedure was performed 
by using a diathermal electrocauterizer with a wire 
loop. The size of the loop was determined according to 
colposcopic examination of the lesion. The specimen was 
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CIN-1 or lesser lesions. 
 Complications of LEEP were; intraoperative cervical 
suturing requirement or postoperative bleeding from 
cervix that needs hemostatic interventions and infections. 
 Statistical analyses was done with SPSS software 
version 11.5. Chi-square test was used as a univariate 
analysis. Intergroup analysis is done with Wilcoxon test. 
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Results 
 During the period, 176 women with minor cytological 
abnormalities underwent colposcopy and histopathological 
evaluations. According to see and treat approach immediate 
LEEP was performed to 38 women. Colposcopy directed 
biopsy (CDB) was performed to 138 women. Among these, 
in 32 women, pathology revealed CIN2/3 lesions. LEEP 
was performed following CDB to these patients so called 
“three step approach”. To six women because of pesistant 
CIN-1 lesions, LEEP is performed. The preeceding pap 
smears of 176 women were ASCUS in 120 women and 
LGSIL in 56 women. Ages of the patients were between 
20-67 years, and mean age was 34±9.1 years. Eighteen 
(10.2%) women were postmenopausal and 158 (89.8%) 
women were premenopausal. Seventy (39%) women 
were nulliparous. Of the 138 women whom CDB was 
performed, 98 had ASCUS and 40 had LGSIL cytology. 37 
had a pathologic diagnosis on cervical biopsy as CIN 2 or 
greater: 22 with CIN 2, 13 with CIN 3 and 2 with invasive 
cancer. Of the remaning 101 patients, 50 had CIN 1 and 
51 had no lesions. These results indicate that the CIN 2 
or greater lesions on CDB was 26.8 % in minor cervical 
abnormalities. CDB results with respect to cytologies are 
presented in table 1. According to pathological results of 
CDB, 20.4 % of the ASCUS cytologies and % 42.5 of 
the LGSIL cytologies were found to be CIN 2 or greater. 
Mean number of biopsies was 3.9±1.8 (minimum 1 and 
maximum 12). According to number of biopsies patiens 
grouped into two, one group had less than 3 biopsies 
and second group had 3 or more biopsies. Three or more 
biopsy taken group was more sensitive to detect CIN 2 
and greater lesions. 
 In “see and treat” group the recognition of CIN2/3 is 
found as 39.4%. The clinical charecteristics and histology 
results of the study objects regarding to LEEP indications 
are listed in table 2. In “three step” group, diagnosis 
of CIN2 and worse lesions are higher than CIN1 and 
lesser lesions (p<0.05). In “see and treat” group, CIN1 
and lesser lesion rates are more than CIN 2 and greater 
lesions (p<0.05). Comparing these two groups according 
to detection of CIN 1 and lesser lesions or CIN2 and 
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Finally, the overtreatment rate in see and treat group is 
60% and in three step group it is 25%. Three step group 
was more likely to have higher grade lesions (p<0.05). 
Another six women underwent LEEP in despite of CIN-
1 results; because of persistent CIN-1 lesions or patients 
anxiety for maximum safety.
 There were 8 women in whom the biopsy results 
was CIN 2 or greater but had negative (CIN1 or normal) 
LEEP results (Table 2). In this group the mean CDB 
number was 4.5±0.9. When the LEEP and CDB results 
were similar, CDB number was 4.5±1.8. There was no 
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and LEEP was 19.5±14.3 days (4-65 days). This period 
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due to additional CDB procedure rather than direct LEEP.
Table 1. Histologic Results of LEEP Specimens in 
Patients with ASC-US / LG-SIL Cytology
LEEP RESULTS See and treat Three step 
 n  (%) n   (%)
???????????? ?????????? ?????????
  CIN-1 16  (42.1) 4  (12.5)
  CIN-2 5  (13.1) 13  (40.6)
  CIN-3 10  (26.3) 11  (34.3)
Total 38 32
*Overtreatment rate 23  (60.7) 8     (25)
*For the see-and-treat group overtreatment rate is 60.7 % and for the three-step 
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Table 2. Colposcopy Directed Biopsy Results According 
to Initial Cervico-Vaginal Smear Results
  Colposcopy directed biopsy results Total
 No lesion CIN-1 CIN-2+ 
   CIN-2      CIN-3     SCC
 n (%) n (%) n (%) n (%) n (%) n (%)
Cervico-vaginal smear results
  ASC-US 43(43.8) 35 (-35.70) 11 (-11.20) 8 (-8.10) 1 (-1.00) 98 (-100)
  LG-SIL 8(-20) 15(-37.50) 11(-28.40) 5(-12.50) 1(-2.50) 40(-100)
  Total 51(36.9) 50(36.2) 22(-15.90) 13(-9.40) 2(-1.40) 138(-100)
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Discussion
See and treat approaches, especially LEEP, are 
investigated regarding to overtreatment rates since their 
introduction. The effectiveness of see and treat approaches 
depend on colposcopic findings. To decrease the 
overtreatment rates, patients must have a high probability 
of having CIN2/3 before undergoing this procedure. 
There is intra and inter observer variability in colposcopic 
examination and this may cause overtreatment. Patients 
may suffer unnecessary bleeding, infection and premature 
delivery due to overtreatment. According to Cho’s opinion, 
“see and treat” protocol is only appropriate when an 
experienced colposcopist can differentiate low grade from 
high grade lesions (Cho and Kim. 2009).
?????????????? ????? ??? ??????? ??? ???? ??????????? ???
women whose excised specimens contained CIN 1 or less 
by the American Society for Colposcopy and Cervical 
Pathology (ASCCP) (Luesley and Leeson, 2010). In the 
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overtreatment rates of two approaches (see and treat and 
three step strategy).
Altough there are some controversies in “see and 
treat” protocol and its overtreatment rates, similarly the 
CDB and its necessity is being evaluated in recent years. 
In a study of Byrom and collagues, in HGSIL lesions on 
cervical smears or colposcopic examinations, CDB results 
were found to underevaluate the disease (Byrom et al., 
2006). Similarly, Sadan and co-workers concluded that 
CDB did not improve the accuracy of diagnosis, it also 
delayed the treatment, and caused increased emotional 
anxiety in patients (Sadan et al., 2007). On the other 
hand Duesing et al. designed a study for the accuracy of 
preoperative assesment of CIN with cytology and CDB. 
They concluded that CDB is an accurate method. The 
concordance rate was higher for CIN2/3 (95.1%) when 
compared with CIN1 (63.2%) (Duesing et al., 2012). We 
did not perform the excisional procedure (LEEP) for all 
of the CIN 1 cases; so concordance rate between CDB 
and LEEP was not evaluated statistically in our study. 
The detection rate of CDB for CIN 2/3 lesions is 26.8%, 
whereas this rate is 39.4% in immediate LEEP group.This 
difference can be the result of application direct LEEP to 
high risk group.
See and treat approach is evaluated only for HGSIL 
cytologies in majority of studies. (Byrom et al., 2006; 
Sadan et al., 2007; Cho and Kim., 2009; Zhi Gang Li et 
al., 2009; Paula et al., 2012) Especially in low resource 
countries women with HSIL can be managed effectively 
using the see and treat approach with LEEP (Zhi Gang 
Li et al., 2009). A study from Brazil, concluded that for 
???????????????????????????????????????????????????????
treat by LEEP outweight the risk of overtreatment (Paula 
et al., 2012). In Zang Li’s study overtreatment rate was 
7,8% and acceptable (Zhi Gang Li et al., 2009). According 
to the 2006 American Society for Colposcopy and Cervical 
Pathology (ASCCP) guidelines see and treat approach is 
an alternative for management of women with HGSIL. But 
the role of LEEP is not investigated for the minor cytologic 
abnormalities as in HGSIL lesions. ASCUS/LGSIL Triage 
Study (ALTS) showed that only 15% of women referred 
with ASCUS and %25 of women referred with LGSIL 
cytology had biopsy-proven CIN2/3. (Solomon et al., 
2001; ALTS group 2003)) There are high overtreatment 
rates. So see and treat approach should be evaluated for 
these patients.In our study CIN 2 and greater lesions were 
seen 20.4 % in the ASCUS cytology and 42.5 % in LGSIL 
group. These rates are relatively higher when compared to 
previous studies. It may be due to high number of CDB’s. 
Only a few publications like Cho’s study investigated 
ASCUS/LGSIL cytologies separately. In his study, respect 
the initial cervical smears, in the HGSIL cytology cases the 
addition of CDB did not reduce the ratio of overtreatment 
because the diagnosis did not differ at the initial and 
???????????????????????????????????????????????????????
diagnosed as invasive carcinoma and immediately treated 
the next day. But in the LGSIL and ASCUS cytology cases 
there were more cases of correct treatment in three step 
group than in see and treat group (63.3% versus 17.8%). 
And the author suggests that it was not appropiate to 
perform a LEEP without CDB in patients with low grade 
lesions found on cervical cytology (Cho and Kim, 2009). 
In Augkul’s study overtreatment rate was 22.9% for 
??????????????????????????? ???????? ?????????????????
rate however was only 7% in women who had either pap 
smears or colposcopy suggesting a HGSIL.In women 
with ASCUS/LGSIL smears and only low grade lesions 
on colposcopic examination,rate of overtreatment was 
extremely high (68%) (Ae-Aungkul et al., 2011). In our 
?????? ???????? ????????????????? ?????????????????? ??????
are high in see and treat group than three step strategy 
(60.8% versus 25%). 
Another issue is number of biopsies taken in three 
step strategy group. In 2012, Moss et al reported a study 
to determine the accuracy of the CDB to detect high 
grade CIN. In this study women with ASCUS and LGSIL 
cytologies with minor colposcopic changes had single 
CDB followed by LEEP. They concluded that single CDB 
???????????????????????????????????????????????? ??????????
(Moss et al., 2012). In Nina’s study hestated that accuracy 
of colposcopic biopsy (85.8 % overall concordance rates) 
depends on the number of biopsises taken per patient 
(Sadan et al., 2007). In study of Gage, colposcopy with 
guided biopsy or biopsies detects approximately two thirds 
of CIN 3+. Although the sensitivity of the procedure does 
???????????????????????????????????????????????????????????
greater when two or more biopsies are taken(Gage et al., 
2006). In Pretorius study he concluded that sensitivity 
of colposcopy for CIN 3+ varies widely. Performing 
EndoCervical Curetage (ECC) with up to 4 random 
biopsies increases the diagnosis of CIN 3+. (Pretorius 
et al., 2011)
In our study CDB were performed in all suspectious 
areas and multiple biopsies were taken. In CDB 
groupdetection of CIN 2 or greater lesions increased 
with 3 or more biopsies. High number of CDB may cause 
negative LEEP results. In current study, there were 8 
patients who had CIN2/3 results in CDB but their LEEP 
results had negative or CIN 1. Possible explanation is the 
high grade dysplasia may be completely removed with 
multiple CDB. In this situation, overtreatment rates should 
be less than 25% in three step group. 
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The most common complication following LEEP is 
perioperative bleeding and postoperative infections. In our 
study complications were seen in 6.3 % of the patients. 
The limitations of current study are retrospective 
nature and small number of the sample size. Upto date 
only a few number of publications have been made for 
CDB and LEEP results in ASCUS/LGSIL cytology, but 
there are many publications for HGSIL cytology group. 
In this group see and treat strategy is thought to be 
appropriate. But according to our results in patients with 
ASCUS/LGSIL CDB should be performed before LEEP 
to prevent overtreatment rates. CDB should be performed 
to all suspected areas and more than 2 biopsies should be 
?????????????? ????????????? ?????????????????????????????
were taken, underdiagnosis decreases and more patients 
have correct terapies.
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